Public, NASDAQ:THRX
NASDAQ Global Market
2008-07-02 13:37:18 - www.companiesandmarkets.com adds new report - Theravance Inc - Premium Company Profile
Date: Wed, 02 Jul 2008 11:56:20 GMT
Tags:
2008-07-02 13:37:18 - www.companiesandmarkets.com adds new report - Theravance Inc - Premium Company Profile
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
Theravance is a biopharmaceutical company focused on the discovery , development and commercialization of small molecule medicines for the treatment of diseases including respiratory disease ...
Zacks Equity Research Analyst Blog GSK Boosts Theravance, Near-Term
Date: Thu, 26 Jun 2008 14:24:36 GMT
Tags:
Zacks Equity Research Analyst Blog GSK Boosts Theravance, Near-Term
Zacks.com - Jun 26, 2008
Zacks.com - Jun 26, 2008
We expect the US launch of Theravance , Inc . ' s ( THRX ) Telavancin , for the treatment of complicated skin infections , to occur by August , provided the company satisfactorily deals with ...
Theravance to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Date: Wed, 28 May 2008 20:24:15 GMT
Tags:
Theravance to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Primenewswire (press release) - May 28, 2008
Primenewswire (press release) - May 28, 2008
SOUTH SAN FRANCISCO , Calif . , May 28 , 2008 ( PRIME NEWSWIRE ) - - Theravance , Inc . ( Nasdaq : THRX ) announced today that Rick E Winningham , Theravance's Chief Executive Officer , is scheduled ...
Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
Date: Wed, 28 May 2008 14:22:29 GMT
Tags:
Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
PR Newswire (press release) - May 28, 2008
PR Newswire (press release) - May 28, 2008
WALTHAM , Mass . , May 28 / PRNewswire / - - Decision Resources , one of the world's leading research and advisory firms for pharmaceutical and healthcare issues , finds that the launches of ...
Seth Klarman Buys WellPoint Inc., Theravance Inc., Sapphire Industrials, Sells SLM Corp., The First American Corp., Portland General Electric Company
Date: Thu, 15 May 2008 14:56:54 GMT
Tags:
Seth Klarman Buys WellPoint Inc., Theravance Inc., Sapphire Industrials, Sells SLM Corp., The First American Corp., Portland General Electric Company
GuruFocus.com - May 15, 2008
GuruFocus.com - May 15, 2008
rkets.WellPoint Inc . has a market cap of $26.6 billion ; its shares were traded at around $50.94 with a P / E ratio of 9.36 and P / S ratio of 0.44.Seth Klarman initiated holdings in Theravance ...
Russell 2000 adds 53 health care companies (AP)
Date: Mon, 30 Jun 2008 18:16:09 Etc/GMT
Tags:
More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were removed from the index.
GSK Boosts Theravance, Near-Term (Zacks.com)
Date: Thu, 26 Jun 2008 13:52:48 Etc/GMT
Tags:
THERAVANCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online)
Date: Thu, 19 Jun 2008 21:17:19 Etc/GMT
Tags:
No Love for Antibiotics From the FDA (at Motley Fool)
Date: Fri, 30 May 2008 19:44:01 Etc/GMT
Tags:
Theravance to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference (PrimeNewswire)
Date: Wed, 28 May 2008 20:05:00 Etc/GMT
Tags: